Glucagon Like Peptide 1 Agonist Market: Transforming Diabetes and Metabolic Disease Management
The management of type 2 diabetes and obesity has evolved with the development of medicines that influence appetite, blood glucose regulation, and metabolic processes. Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 agonists, are an important class of medicines used in selected patients. These therapies mimic the activity of the naturally occurring GLP-1 hormone and help...